Industrial Dermatitis Across 369 Singapore Notifications
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
Reader question: What can this study tell workers, families and occupational-health teams—and what would go beyond the evidence? This review keeps every number attached to its population, denominator, comparator and timepoint.
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 369 notified industrial-dermatitis cases within 3,472 confirmed occupational-disease notifications in Singapore from 1996 through 1998. |
| Design | Narrative occupational-surveillance review incorporating notification data and selected workplace or clinic series. |
| Comparator | Industrial dermatitis versus other occupational-disease notifications, plus industry-specific case and population series. |
| Timepoint | Primary notification window 1996–1998, with related study findings summarized. |
| Key result | Industrial dermatitis represented 11% of 3,472 confirmed notifications; occupational allergic contact dermatitis comprised about one-third of the 369 dermatitis notifications. The authors considered under-notification likely. |
| Funding/conflict context | No grant or conflict-of-interest statement appears in the PubMed record retrieved for this review. |
What was actually measured?
Industrial dermatitis represented 11% of 3,472 confirmed notifications; occupational allergic contact dermatitis comprised about one-third of the 369 dermatitis notifications. The authors considered under-notification likely.
The paper makes an important distinction between surveillance notifications and workplace population studies. A low notification count can coexist with meaningful burden when reporting is incomplete.
The denominator defines the scope. A patch-test clinic, selected case series, compensation registry, online questionnaire, workplace cohort and general-population survey answer different questions. A percentage from one cannot be silently transferred to the others.
What the result does not prove
The article combines multiple datasets with different denominators and methods. Under-reporting, historical exposure patterns and absence of a single analytic comparison limit incidence inference.
Association, timing and biological plausibility can strengthen an occupational interpretation, but observational evidence cannot automatically establish individual causation. Referral patterns, reporting practices, task mix, protective equipment, nonwork exposures and access to care may all change an estimate.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors' conclusions, this interpretation or any product.
Exposure detail matters more than the job label
Workers with the same title can handle different materials for different durations. Useful documentation identifies the exact product or process, the route of contact, glove or PPE material, wetness, friction, heat, dust, splash potential, frequency and how symptoms change away from the task.
A symptom survey can identify a pattern, a clinical examination can refine the differential diagnosis, and patch testing can identify delayed sensitization. None of those steps alone proves that a workplace material caused an individual condition. Clinical relevance still requires a credible exposure and time course.
Questions worth recording
- Which task, product, glove, tool, metal, resin, cleanser, food, plant, dust or surface came before symptoms?
- Where did the change begin, and did it improve on days away or after a process or PPE change?
- How often were hands wet, washed, disinfected, occluded, rubbed, heated or exposed to cold?
- Were labels, ingredient information and safety-data sheets reviewed with occupational health?
- Did the problem affect dexterity, sleep, pace, attendance, work quality or safety?
Prevention comes before cosmetic care
Substitution, closed systems, local exhaust, splash control, safer cleaning methods, training and correctly selected protective equipment address exposure at its source. Gloves are not automatically protective: material, fit, breakthrough time, sweating, reuse and rubber accelerators all matter.
Do not deliberately place workplace products on skin to test a theory. Persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function warrant professional evaluation.
Primary research and guidance
- Primary research record: PubMed PMID 11327405
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: eczema skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, neutralizes workplace chemicals, is appropriate for every person, or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Occupational Allergy in 151 of 946 Iranian Patients
- Testing Five Workplace Cleansers in 25 Healthy Volunteers
- Epoxy Allergy Among 5,604 Suspected Occupational-Dermatitis Patients
- Standard-Series Findings in 230 Suspected Occupational-Allergy Patients
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace-safety determination.